| Anderson (formerly Broder), Elizabeth (LianBio 202103 VP Communications + IR before MeiraGTx) |
Public Relations Manager / Investor Relations Manager |
LianBio |
|
| Crawford-Brunt, Andre (Braavos Investment Advisors 202102 General Partner) |
Board member, non-executive |
Braavos Investment Advisers |
|
| Davis, Roy (Medica Group plc 201810 Chairman before Optos plc CEO + Gyrus Group plc CEO) |
Board member, non-executive |
Medica Group plc |
|
| Earl, Michael (Celtic Pharma 201301 + Pro Bono Bio 201209 COO) |
Partner (venture partner) |
Auven Therapeutics (Group) |
|
| Fry, Nigel (Schauenburg 202309– CEO of Schauenburg Analytics Group before Antylia Scientific + GE Healthcare) |
Chief Executive Officer (CEO) |
Schauenburg (Group) |
|
| Knowles, Tuomas (Fluidic Analytics 201809 CSO + Professor at Univ Cambridge) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Fluidic Analytics Ltd. |
|
| Mather, Nicole (United Kingdom (govt) 2014–201711 Director of Office for Life Sciences LEFT 11/17) |
Cluster Manager |
United Kingdom (GB) (govt) |
|
| McLeod, Kristen (United Kingdom (govt) 201711– Director of Office for Life Sciences before Dept of Health) |
Cluster Manager |
United Kingdom (GB) (govt) |
|
| Meredith, Jess (Differing Minds 202210 CEO + Founder) |
Chief Executive Officer (CEO) |
Differing Minds CIC |
|
| Oldfield, Steve (Teva 201506– General Manager UK +IE before Sanofi Managing Director UK+IE) |
General Manager (management) |
Teva (Group) |
|
| Parrett, William G. (Deloite Touche –2007 retired) |
n. a. |
Deloitte Touche Tohmatsu (Group) |
|
| Patrick, Denis (Pfizer 202007 Managing Partner at Pfizer Ventures) |
Managing Partner (investment firm) |
Pfizer (Group) |
|
| Quinn, Belinda (United Kingom (govt) 201604– CEO of Precision Medicine Catapult before Chief Clinical Officer) |
Chief Executive Officer (CEO) |
United Kingdom (GB) (govt) |
|
| Sullivan, Kevin (Principal Forensic Services 201510 Director before at UK Forensic Science Service) |
Consultant (economic/technology) |
Principal Forensic Services |
|
| Winkler, Frank (Univ Heidelberg + DKFZ 201909 Professor + Co-Founder of Divide & Conquer) |
Professor |
University of Heidelberg (Ruperto Carola) |
|
| Xu, Joanne (SoftBank 202106 Partner at SoftBank Investment Advisers + 202106– Board Director at Exscientia) |
Partner (venture partner) |
SoftBank (Group) |
|
| Malcolm, Alastair (Applied Microarrays 200705 founder before GE Healthcare before Amersham before Motorola) |
Company Founder |
Schott (Group) |
Arizona (federal state) |
| Chiplin, John (Peptech 200601– CEO before Newstar Ventures before ITI Life Sciences before Geneformatics) |
Chief Executive Officer (CEO) |
Arana Therapeutics (Group) |
Australia_ooo |
| Ribon, Denis (ArchiMed 201609 Founder + Managing Director before 3i 200904 Head European Healthcare) |
Managing Partner (investment firm) |
ArchiMed (Group) |
Auvergne-Rhône-Alpes (region) |
| Britten, Cedrik (Immatics 202006– CMO before GSK VP + Head of Oncology Cell Therapy Research Unit + BioNTech) |
Chief Medical Officer (CMO) |
Immatics (Group) |
Baden-Württemberg (federal state) |
| Clark, Tim (Univ Erlangen-Nuremberg 200411 Professor) |
Professor |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Bayern (federal state) |
| Crabtree, Lucinda (MorphoSys 202307c– CFO before Autolus + Woodford Investment + Panmure Gordon + Goldman Sachs) |
Chief Financial Officer (CFO) |
MorphoSys (Group) |
Bayern (federal state) |
| Fenzl, Edgar J. (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
Bayern (federal state) |
| Foulsham, Lawrence (Siemens 202310 Business Manager for Molecular Imaging at Siemens Healthineers GB&I) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Bayern (federal state) |
| Krauss, Martin (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
Bayern (federal state) |
| Lee, Denise (Metronomia Clinical Research GmbH 202007– Managing Director before Allergy Therapeutics) |
Managing Director |
Metronomia Clinical Research GmbH |
Bayern (federal state) |
| Litzka, Olivier (Andera Partners 202104 Partner Life Sciences + Coordinator DACH before EdRIP + 3i Venture Healthcare) |
Partner (venture partner) |
Andera Partners (FR) |
Bayern (federal state) |
| Malkomes, Axel-Sven (Medigene 201904 – CFO + Chief BusDev Officer before Barclays + Société Générale + 3i + Merck KGaA) |
Chief Financial Officer (CFO) |
Medigene (Group) |
Bayern (federal state) |
| Grant, Angus (BeiGene 202007– Chief Business Executive before Dementia Discovery Fund + Celgene) |
Chief Executive Officer (CEO) |
BeiGene (Group) |
Beijing (Peking) (province) |
| Wang, Zilong (Allen) (HEL Group 202302– promoted to General Manager of H.E.L. China before Malvern Pananalytical) |
General Manager (management) |
HEL (H.E.L.) (Group) |
Beijing (Peking) (province) |
| Gilham, David (Celyad 201609– VP RnD before Univ Manchester MCRC + Bristol Univ) |
Research & Development Manager |
Celyad (Group) |
Belgium_o |
| Powell, Steven (eTheRNA CEO 202006 before Macrophage Pharma 201705 CEO) |
Chief Executive Officer (CEO) |
eTheRNA (Group) |
Belgium_o |
| Cornall, Jim (Inova Software 202205– Editor-in-Chief at Labiotech.eu formerly Editor at DairyReporter) |
Editor / Publisher |
Inpart (Group) |
Berlin (federal state) |
| Lucke, Marc-Olivier (Atlantic Labs Manager GmbH 201909) |
n. a. |
Atlantic Labs Manager GmbH |
Berlin (federal state) |
| Jones, Richard (Adrenomed 202203– CEO before Fusion Antibodies formerly Novartis + GSK + Genzyme + Shire) |
Chief Executive Officer (CEO) |
Adrenomed AG |
Brandenburg (federal state) |
| Liebeke, Manuel (MPI Bremen before Imperial College London) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Bremen (federal state) |
| Francis, Nick (fomerly M:Communications 201104) |
Public Relations Manager / Investor Relations Manager |
UCB (Group) |
Brussels (region) |
| Amado, Rafael G. (Allogene 201909– EVP RnD + CMO before Adaptimmune + GSK + Amgen + UCLA) |
Chief Medical Officer (CMO) |
Allogene Therapeutics Inc. (Nasdaq: ALLO) |
California (federal state) |
| Farooq, Khurem (Aiolos Bio 202301– CEO + Co-Founder before Gyroscope Therapeutics + Genentech) |
Chief Executive Officer (CEO) |
GSK (Group) |
California (federal state) |
| Heath, Gregory F. (Illumina 200803– SVP + General Manager Diagnostics Business Unit before Roche Molecular Systems |
General Manager (management) |
Illumina (Group) |
California (federal state) |
| Hoefer, Eric (Arcus Biosciences 201906– CCO before AstraZeneca + Roche/Genentech + Glaxo Wellcome) |
Chief Commercial Officer (CCO) |
Arcus Biosciences Inc. (NYSE: RCUS) |
California (federal state) |
| MacKinnon, Lachlan (Replay 202208 CEO + Co-Founder before Oxford Science Enterprises) |
Chief Executive Officer (CEO) |
Replay (Group) |
California (federal state) |
| Marks, Ian (Salesforce 202108 VP Life Sciences before GSK + Novartis) |
President/Director/Head Business Group/Unit/Division |
Salesforce.com Inc. (NYSE: CRM) |
California (federal state) |
| McComb, Joel (Illumina 200803– SVP + General Manager Life Sciences Business Unit before GE Healthcare before Innovadyne) |
General Manager (management) |
Illumina (Group) |
California (federal state) |
| Mohan, Raju (Ventyx Biosciences 202103 CEO + Founder before Escalier Biosciences + Akarna Therapeutics) |
Chief Executive Officer (CEO) |
Ventyx Biosciences Inc. |
California (federal state) |
| Rainin, Ken (Rainin + 1970 co-founder of Anachem) |
Company Founder |
Mettler-Toledo (Mettler Toledo) (Group) |
California (federal state) |
| Sanchez Sarmiento, Rebeca (Insightful Science 202111– CFO of Insightful Science + Dotmatics before InvestCloud + ATTOM) |
Chief Financial Officer (CFO) |
Insightful Science (Group) |
California (federal state) |
| Sundaram, Senthil (Terns Pharmaceuticals 202101 CEO before NightstaRx + Intercept + Lehman Brothers/Barclays) |
Chief Executive Officer (CEO) |
Terns Pharmaceuticals, Inc. |
California (federal state) |
| Vidian, Armen (DCVC 2020 Partner) |
Partner (venture partner) |
DCVC (Data Collective) (Group) |
California (federal state) |
| Wilson, Ian (ImaginAb 201902– CEO joined 201802 as COO before Edinburgh Molecular Imaging + Xstrahl Ltd) |
Chief Executive Officer (CEO) |
ImaginAb Inc. |
California (federal state) |
| Carter, Tina (GenScript 202311 Corporate Communications Lead at Legend Biotech) |
Public Relations Manager / Investor Relations Manager |
GenScript (Group) |
Cayman Islands (British Overseas Territory) |
| Fang, Guowei (GenScript 202311 CSO + Head of Business Development at Legend Biotech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GenScript (Group) |
Cayman Islands (British Overseas Territory) |
| Sun, Eliza (Hansoh Pharmaceutical 202310 Executive Board Director) |
Board member, executive |
Hansoh Pharmaceutical (Group) |
Cayman Islands (British Overseas Territory) |
| Takáts, Zoltán (MediMass 2008– Founder + Professor at Imperial College London) |
Company Founder |
Waters (Group) |
Central Hungary (region) |
| Boghossian, John (Quercis Pharma 202104– CEO before VP of Operations at Compass Pathways + Boston Consulting) |
Chief Executive Officer (CEO) |
Quercis Pharma (Group) |
Central Switzerland (region) |
| Veraart, Manon (Quercis Pharma 202104– CBO before Compass Pathways + Boston Consulting + Goldman Sachs) |
Chief Executive Officer (CEO) |
Quercis Pharma (Group) |
Central Switzerland (region) |
| Benhamida, Sonia (Kreos Capital 202307 Principal) |
Principal (venture capital) |
Kreos Capital (Group) |
Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| Escher, Dominik (Belleveue 201001 Managing Partner at BB Pureos Bioventures before ESBATech CEO + Founder) |
Managing Partner |
Bellevue (Group) |
Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| Farrell, Lindsay (BioPharmaSpec 201802 Head of Business Development) |
Business Development Manager / Strategy Manager |
BioPharmaSpec (Group) |
Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| PetitBon, Maurizio (Kreos Capital 201401 General Partner joined 1998 before PMA Europe + SRI Intl) |
General Partner (venture partner) |
Kreos Capital (Group) |
Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| Reason, Andrew (BioPharmaSpec 201802 CEO) |
Chief Executive Officer (CEO) |
BioPharmaSpec (Group) |
Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| Viehbacher, Christopher A. (Chris) (Biogen 202307 CEO before Gurnet Point Capital + Sanofi + GSK) |
Managing Partner |
BERTARELLI Group (family of Ernesto Bertarelli) |
Channel Islands (Non-Commonwealth / Non-EU tax haven) |
| Zhou, Jason (China Resources Group 202008 CEO + Managing Director of CR-CP Life Science Fund) |
Chief Executive Officer (CEO) |
China Resources Group (Group) |
China_o |
| Zou, Johnny (Primavera Capital 202109 at Primavera Venture Partners) |
Investment Manager |
Primavera Capital (Group) |
China_o |
| Ljungqvist, Ingrid Charlotta (Lotta) (General Electric 201709 CEO of GE Nordics) |
Chief Executive Officer (CEO) |
General Electric (Group) |
Connecticut (federal state) |
| Dudfield, Phil (Galapagos 201301– Head of new Fidelta division before BioFocus DPI 200709 VP Discovery Products) |
President/Director/Head Business Group/Unit/Division |
Selvita (Group) |
Croatia_o |
| May, Jean-Christophe (Bavarian Nordic 202001– CCO before GSK Vaccines) |
Chief Commercial Officer (CCO) |
Bavarian Nordic (Group) |
Denmark_o |
| McCullagh, Keith (Santaris Pharma 200506 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Denmark_o |
| Allenby, Gary (Aurelia Bioscience 202106 Co-Founder) |
Company Founder |
Charnwood Molecular (Group) |
East Midlands (region) |
| Allin, Steve (Charnwood Molecular 202207– Board Advisor + Investor before 1998–202207 CEO + Co-Founder) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Charnwood Molecular (Group) |
East Midlands (region) |
| Ash, Nicholas Watson (Nick) (Source Bioscience 200812 Managing Director) |
Managing Director |
Source BioScience (Group) |
East Midlands (region) |
| Badiani, Kamal (Pepceuticals 202309 Managing Director) |
Managing Director |
Biosynth (since 9/22) (Group) |
East Midlands (region) |
| Biddell, Chris (Vivascience 200008 founder + co-partner) |
Company Founder |
Sartorius (Group) |
East Midlands (region) |
| Bond, John (Univ Leicester 201211 Lecturer Dept of Chemistry) |
Researcher (university / research institute) |
University of Leicester |
East Midlands (region) |
| Brown, Claire (BioCity 201908 Director of Investment) |
Investment Manager |
Pioneer Group, The (WAPG) (Group) |
East Midlands (region) |
| Brown, Ian (Minerva Scientific 201009 Technical Director) |
Technical Manager |
Minerva Scientific Ltd. |
East Midlands (region) |
| Chadwick, Mark (Charnwood Molecular 202106– Chief Commercial Officer formerly Physiomics 201104 CEO) |
Chief Commercial Officer (CCO) |
Charnwood Molecular (Group) |
East Midlands (region) |
| Chaudhuri, Bob (De Montfort Univ 201301 Professor) |
Professor |
De Montford University (DMU, Leicester, UK) |
East Midlands (region) |
| Cheema, Daljit (Pharmaseal 201602 CEO + Co-Founder before Parexel + ClinPhone) |
Chief Executive Officer (CEO) |
Pharmaseal International Ltd. |
East Midlands (region) |
| Clewlow, Paul J. (Sygnature Discovery 202101– Board Member before SVP Business Development) |
Business Development Manager / Strategy Manager |
Sygnature Discovery (Group) |
East Midlands (region) |
| Creaser, Colin (Loughborough Univ 201609 Professor at Dept of Chemistry) |
Professor |
Loughborough University |
East Midlands (region) |
| Crocker, Glenn (BioCity Nottingham 201201 CEO) |
Chief Executive Officer (CEO) |
Pioneer Group, The (WAPG) (Group) |
East Midlands (region) |
| Dodgson, Kathy (Aurelia Bioscience 202106 Co-Founder) |
Company Founder |
Charnwood Molecular (Group) |
East Midlands (region) |
| Dovlatova, Natalia (Platelet Services Ltd 2018– CEO + Co-Founder before Platelet Solutions + Univ Nottingham) |
Chief Executive Officer (CEO) |
Platelet Services Ltd. |
East Midlands (region) |
| Freeth, Jim (Retrogenix Ltd 201211 Managing Director) |
Managing Director |
Retrogenix Ltd. |
East Midlands (region) |
| Hall, Matthew (Oncimmune 201906 CFO + 201904– Managing Director at Oncimmune Germany GmbH) |
Chief Financial Officer (CFO) |
Freenome (Group) |
East Midlands (region) |
| Hamilton-Fairley, Geoffrey (Oncimmune 201810– Vice Chairman of the Board before CEO 2005–201809) |
Board member, non-executive |
Freenome (Group) |
East Midlands (region) |
| Herschel, Candice (LifeScience Connect 202309 Head of Community) |
n. a. |
LifeScience Connect Ltd. (LifeScience ORG) |
East Midlands (region) |
| Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies) |
Chief Executive Officer (CEO) |
Freenome (Group) |
East Midlands (region) |
| Hirst, Simon (Sygnature Discovery 201112 CEO + Founder) |
Chief Executive Officer (CEO) |
Sygnature Discovery (Group) |
East Midlands (region) |
| Hoad, Simon (We Are Pioneer 202206 Executive Director) |
Board member, executive |
Pioneer Group, The (WAPG) (Group) |
East Midlands (region) |
| Howarth, Simon (CompanDx Ltd 201207 Chief Executive) |
Chief Executive Officer (CEO) |
CompanDX Ltd. |
East Midlands (region) |
| Jeffreys, Alec (Leicester Univ 200509) |
Professor |
University of Leicester |
East Midlands (region) |
| Jones, Steve (Locate Therapeutics Ltd 201412 CFO) |
Chief Financial Officer (CFO) |
Locate Bio Ltd. |
East Midlands (region) |
| Jordison, Louisa (Sygnature Discovery 201902– Director of Strategic Planning before Experian + Deloitte + KPMG) |
Business Development Manager / Strategy Manager |
Sygnature Discovery (Group) |
East Midlands (region) |
| Kawaletz, Gregor (Albumedix 202006– CCO before IDT Biologika + Next Pharma + Catalent Pharma Solutions) |
Chief Commercial Officer (CCO) |
Sartorius (Group) |
East Midlands (region) |
| King, Gareth (Critical Pharmaceuticals Ltd 201302 CEO) |
Chief Executive Officer (CEO) |
Critical Pharmaceuticals Ltd. |
East Midlands (region) |
| Lawrence, Andrew (Histologix Ltd 201809–202008 Managing Director RETIRED 8/20) |
Managing Director |
Intelligent Tissue Group (Group) |
East Midlands (region) |
| Leaves, Nick (Medical Solutions 200708 Head of Operations) |
n. a. |
Source BioScience (Group) |
East Midlands (region) |
| Lindstrom, Anders (Andy) (Sygnature Discovery 201807c– Director of Marketing before Siemens + Experian) |
Sales Manager / Marketing Manager |
Sygnature Discovery (Group) |
East Midlands (region) |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
